Mutations in the von Hippel-Lindau (VHL) gene are involved in the VHL family cancer syndrome and sporadic renal cell carcinoma. Previous studies indicated that VHL-induced growth arrest required high cell density and growth on extracellular matrix. In the present study, VHL protein (pVHL) levels were observed to be dramatically increased in cells grown to high cell density compared to cells grown at low cell density. Reverse transcription-polymerase chain reaction and Northern blot analysis indicated that VHL mRNA levels were equivalent in sparse and dense cells. The pVHL was rapidly degraded when cell-cell contact was disturbed by trypsinization or EDTA release. Treatment of cells with a proteasome inhibitor blocked the degradation of pVHL. Using a set of VHL deletions fused to GFP, a cell densitydependent region (CDDR) was identified and localized to the c-terminus of pVHL. In addition, other members of the VBC protein complex also showed a cell densitydependent regulation similar to pVHL. Cell density regulation of VHL did not require elongin binding and density-dependent regulation of other VBC components was not dependent on pVHL. In addition, hypoxia inducible factor-2a protein levels were elevated in sparse cells with low levels of pVHL and reduced or absent in confluent cells containing abundant VHL. These results indicate that pVHL levels and thus function are tightly regulated by cell-cell signaling. In addition, care must be taken when interpreting studies of VHL function and subcellular localization of cells grown at subconfluent conditions.
Introduction
Germline mutations in the von Hippel-Lindau tumor suppressor gene (VHL) cause VHL disease, a hereditary cancer syndrome characterized by the development of retinal and central nervous system hemangioblastoma, clear-cell renal carcinoma and pheochromocytoma (Latif et al., 1993; Chen et al., 1995) . Tumors develop when the remaining wild-type allele is inactivated in susceptible cells. Somatic mutations leading to loss of function are also reported in the majority of sporadic renal cell carcinomas (Foster et al., 1994; Gnarra et al., 1994) and sporadic central nervous system hemangioblastomas (Kanno et al., 1994; Lee et al., 1998a) . In addition, detection of loss of heterozygosity (LOH) at the VHL gene locus in renal cysts (Lubensky et al., 1996) indicates that disruption of VHL function is an early event in renal carcinogenesis. These findings, combined with the experimental data showing that reintroduction of wild-type VHL into VHL-null renal cells suppressed their ability to form tumors in nude mice Schoenfeld et al., 1998) , has established VHL as a tumor suppressor gene.
Native VHL proteins (pVHL) exist in two forms, a longer VHLp24 MPR (Met-Pro-Arg) protein and a more abundant, smaller VHLp18 MEA (Met-Glu-Ala) protein, the latter of which is generated by internal translation at codon 54 Schoenfeld et al., 1998) . pVHL forms a stable complex with elongin B, elongin C, cullin-2 (cul-2) and Rbx1 (VBC) Pause et al., 1997; Kamura et al., 1999) , which together function as an ubiquitin E3 ligase that regulates the degradation of the hypoxia inducible factor (HIF)-1/2a transcription factors Krieg et al., 2000; Tanimoto et al., 2000) . Therefore, loss of pVHL leads to increased HIF levels and transcription of HIF target genes, such as, vascular endothelial growth factor (VEGF) (Iliopoulos et al., 1996) and subsequent tumor angiogenesis. Disruption of the elongin-binding domain also destabilizes pVHL and leads to its rapid degradation indicating an additional function of the elongin B/C complex (Schoenfeld et al., 2000) . However, the biochemical function(s) of VHL that when disrupted results in VHL disease and tumorigenesis have not been completely established.
Normal cells sense and communicate with their environment through signaling pathways in order to maintain homeostasis and make decisions on cell growth, apoptosis, differentiation and motility. These signaling pathways are often dysfunctional or inopera-tive in tumor cells. One such signaling pathway involves the maintenance of normal cell density through contact inhibition. A functional interplay between cell density and VHL has been suggested by the observation that cell density coupled with VHL expression regulates cell morphology and differentiation in 786-O renal carcinoma cells and VHL-dependent decreases in VEGF are also influenced by cell density (Mukhopadhyay et al., 1998) . We have investigated the regulation of pVHL by cell density. We report that pVHL levels increase with cell density and this effect occurs at the protein level. In addition, other members of the VBC complex are also more abundant under high cell density conditions. We show that both native and ectopically expressed forms of pVHL are regulated by cell-cell contact (i.e., high cell density) in cultured human cell lines. By using VHL-GFP deletion constructs, we have identified a cell density-dependent region (CDDR) within the VHL protein. We also test the prediction that alterations of pVHL by cell density should affect downstream targets of VHL.
Results

Cell density and pVHL expression
Previous experiments in our laboratory indicated that VHL-mediated differentiation and growth arrest were observed only at high cell density . In order to test the notion that VHL protein expression is cell density-dependent, a panel of cell lines from different human tissues including embryonic renal cells (293 T), renal carcinoma (ACHN, Caki-1 and CCF-RC-2), bladder carcinoma (ECV304), renal proximal tubule (HK-2), breast adenocarcinoma (MCF7), lung fibroblast (WI-38) cell lines and 786-O (VHL À/À) cells stably transfected with VHLp24(MPR) and VHLp18(MEA) were seeded at sparse (S) (0.2 Â 10 6 cells cells per 100 mm plate), medium (M) (0.5 Â 10 6 cells per 100 mm plate) and high density (D) (7.0 Â 10 6 cells per 100 mm plate) and analysed by Western blot 24 h later. High-density plates were harvested for Western blot 1 week postconfluency. Strikingly, cells seeded at high density compared to cells grown at lower density showed a several order of magnitude increase in pVHL expression as determined by Western blot analysis using antibodies to multiple VHL epitopes ( Figure 1a and data not shown). To determine whether VHL densitydependent regulation was associated with the duration of time the cells were grown, ECV304 cells were plated at increasing densities and cultured for 24 h. The results showed pVHL accumulated with increasing cell density (data not shown). Although levels of endogenous pVHL varied in different cell lines, all showed densitydependent regulation of pVHL. In addition, the same pattern of density-dependent regulation of pVHL was observed in 786-O cells stably transfected with VHL p24(MPR) and VHL p18(MEA) (Figure 1b ). These and VHLp18(MEA) (MEA-2). Cells were seeded at 0.2, 0.5 and 7.0 Â 10 6 cells per 100 mm plate and were either harvested 24 h post plating from sparse (S) and medium (M) cultures or allowed to grow for 1 week postconfluency to achieve high density (D), respectively. Cells were harvested, lysates were normalized for equal protein loading (40 mg), separated on 13.5% SDS-PAGE and VHL proteins were detected with 11E12 mAb. The same blot was stripped and probed with EF1a mAb to confirm equal amounts of protein were loaded in each lane. The positions of the VHLp24(MPR) (appears as two bands), VHLp18(MEA) and EF1a are marked on the left-hand side experiments indicated that pVHL regulation in cultured human cell lines is highly correlated with cell density and was independent of cell type and origin.
Density-dependent expression of VHL is not transcriptionally regulated
The observation that both endogenously and ectopically expressed pVHL levels were density-dependent suggested that regulation of transcription was not responsible for these observations. To test this prediction, VHL transcription at different cell densities was evaluated. Reverse transcription-polymerase chain reaction (RT-PCR) and Northern blot analysis were performed to assay the level of VHL mRNA at sparse, medium and confluent culture conditions. Multiplex RT-PCR for VHL mRNA amplification using b-actin primers as an internal control demonstrated that VHL mRNA levels were unaffected by cell density (Figure 2a ). These results were confirmed by Northern blot analysis (Figure 2b ).
Cell growth and pVHL expression
To examine the relation between cell density and pVHL levels, confluent CCF-RC2 cells were trypsinized and plated at low density (0.5 Â 10 6 cells per 100 mm plate) and grown over the course of 11 days to high density. Cell lysates were prepared from cells on successive days after plating and analysed by Western blotting with 11E12 mAb. Both MEA and MPR forms of VHL showed similar quantitative changes with increased cell density ( Figure 3a) . Two phases of pVHL accumulation were noted: a rapid phase (days 1-3) and a slower phase of accumulation (days 3-11) (Figure 3b ). Thus, pVHL continued to accumulate as the cells increased in density.
Cell density-dependent regulation of pVHL is independent of soluble factors and cell-extracellular matrix (ECM) interaction
To determine whether secreted factor(s) from dense cell culture might influence pVHL levels, medium from high-and low-density CCF-RC2 cells (Figure 4a , lanes A and B) were transferred to cells plated at low density (Figure 4a , lanes C and D). Cells were grown for an additional 24 h and harvested for Western blot. As shown in Figure 4a , the conditioned media from highdensity cells did not increase pVHL levels, indicating that secreted factor(s) are not responsible for the elevated levels of pVHL in dense cells. Since previous studies identified the requirement of both cell-cell and cell-ECM conditions for pVHL-mediated growth arrest and renal cell differentiation , we sought to determine the role of cell-ECM interactions in controlling pVHL levels. Cells grown on poly (2-hydroxyethyl methacrylate) (poly(HEMA))-coated plates are more spherical and there is little to no cell-ECM interaction, since the cells do not adhere to the substratum. Cells were seeded under sparse and dense conditions on poly(HEMA)-coated plates and harvested for Western blot analysis after 24 h. As shown in Figure 2 Density-dependent expression of VHL is not transcriptionally regulated. (a) RT-PCR expression of VHL in ECV304, Caki-1 and ACHN cell lines. Total RNA was isolated from sparse (S), medium (M) and high-density (D) cultures and 5 mg of total RNA was reverse transcribed using random primers and reverse transcriptase. In all, 1 ml of first-strand cDNA was subjected to multiplex PCR amplification using both VHL and b-actin primers. The lengths of the PCR products are shown at the right side. (b) Northern blot detection of VHL in ECV304 cells under three different density conditions (S, M and D) . Total RNA (15 mg) was run on a formaldehyde agarose gel and hybridized with a radiolabeled VHL probe. The membrane was exposed to X-ray film and subsequently stripped and probed with a radiolabeled b-actin probe. The lengths of b-actin and VHL mRNA are indicated at the right side VHL regulation by cell density S Mohan and RD Burk Figure 4b , cells grown to high density on plastic and poly(HEMA)-coated plates showed increased VHL protein levels, indicating that cell-ECM contact does not play a major role in the density-dependent regulation of pVHL.
VBC complex proteins undergo proteasome-dependent degradation at low cell density
Since density-dependent levels of pVHL were independent of VHL mRNA levels, we next evaluated whether VHL was undergoing enhanced degradation at low cell density. Initial studies indicated that VHL protein levels rapidly declined when confluent cells were released and replated at low density (data not shown). The time course of pVHL change from high cell density to low was evaluated. ECV304 cells were grown 1 week postconfluency, EDTA released, suspended in culture media and collected at 5, 10, 30 min, 1 and 2 h for Western blot analysis. Cells at confluence, prior to release and low-density plating ( Figure 5 control lane labeled scraped), had abundant levels of pVHL compared to cells released with EDTA ( Figure 5 ). These results suggest that pVHL undergoes degradation when cells lose contact with each other. In addition, pVHL was not detected in the culture medium by IP-western (data not shown). To evaluate whether other members of the VBC complex displayed similar regulation, To determine whether the degradation of the VBC complex proteins was mediated through the proteasomal pathway, densely grown cells were replated at sparse conditions and treated with a proteasomal inhibitor (MG-132). A marked increase in pVHL was observed in MG-132-treated cells compared to cells treated with DMSO [MG-132(À)] (Figure 7) . Additionally, several slower migrating bands were detected in MG-132-treated cells, whereas they were not detected in cells treated with DMSO (data not shown). Similar results were obtained for elongin B/C and cul-2 (Figure7 and data not shown), indicating that all VBC-cul-2 complex members undergo proteasomal degradation under sparse conditions. Thus, the entire VBC-cul-2 complex is regulated by cell density. pVHL levels are altered by disruption of E-cadherinmediated cell-cell contact To explore the potential mechanism, we investigated whether cell density-dependent increase in pVHL expression is due to signal(s) mediated by cell-cell contact. Confluent MCF-7 cells were treated with EGTA to disrupt cell-cell contact through chelation of the extracellular calcium required for E-cadherin homophilic binding between cells (Gumbiner, 1996) . After EGTA treatment, the cells were monitored by light microscopy to document morphological changes. At 1 h after treatment with EGTA, MCF-7 cells became rounded and detached from one another. At 6 h, MCF-7 cells had no cell-cell contacts, but the cells remained attached to the plastic dishes. Cells were harvested for Western . At 48 h after plating, conditioned media from plate A (highdensity plate) and plate B (low-density plate) were transferred to plates C and D (low-density plates), respectively. Cells were grown an additional 24 h and harvested by scraping. In all, 40 mg of total protein were separated in a 13.5% SDS-PAGE. (b) Densitydependent expression of VHL is independent of cell-ECM contact. Confluent ECV304 cells were EDTA released and plated on either plastic or poly(HEMA)-coated plates under sparse (S) (0.2 Â 10 6 cells per 100 mm plate) and dense (D) (7 Â 10 6 cells per 100 mm plate) conditions. Cells were harvested after 24 h and equal amounts of protein were resolved by 13.5% SDS-PAGE. VHL was detected with 11E12 mAb. The blots were stripped and probed with EF1a mAb. The positions of the VHLp24(MPR), VHLp18(MEA) and EF1a are indicated on the left side of the figures Figure 5 VHL is degraded upon loss of cell-cell contact. Confluent ECV304 cells were released by treatment with EDTA, resuspended in media at 371 C and kept from settling by gentle agitation until harvest at 5, 10, 30 min, 1 and 2 h. In total, 40 mg of total protein from each time point were separated by 13.5% SDS-PAGE. VHL was detected with 11E12 mAb. The blot was stripped and probed with EF1a mAb. The positions of VHLp24(MPR), VHLp18(MEA) and EF1a are indicated on the left side of the figure. Control lane labeled scraped contains extract from confluent ECV304 cells collected by mechanical detachment using a cell scraper VHL regulation by cell density S Mohan and RD Burk blot analysis at 2, 4 and 6 h post-EGTA treatment (Figure 8 ). Western blot analysis showed that pVHL quantity was significantly decreased 2 h after EGTA treatment and by 4 h pVHL protein was undetectable by Western blotting. In order to determine whether loss of cell-cell contact induced by EGTA also caused changes in E-cadherin expression, E-cadherin protein levels were examined. As expected, E-cadherin protein levels were decreased by 2 h of EGTA treatment and undetectable by 6 h (Figure 8 ).
HIF-2a protein expression is regulated by cell density
Since HIF-2a is regulated by pVHL under normoxia, we tested the prediction that decreased or absent pVHL in sparse cells would result in elevated levels of HIF-2a. (Figure 9 ).
However, 786-O cells under high and low cell density conditions expressed equal amounts of HIF-2a protein (Figure 9 ), indicating that HIF-2a protein levels are regulated by pVHL at high cell density. Density-dependent levels of the VBC complex are regulated by proteasomal degradation. Confluent MEA-2 cells were EDTA released in the presence of MG-132 (lanes 2, 4 and 6) or DMSO (lanes 1, 3 and 5) and replated at 0.2 Â 10 6 per 100 mm plate and collected at 2, 4 and 8 h after plating. pVHL, cul-2 and elongin B were detected by immunoblot. As a positive control for MG-132 activity, the blot was stripped and probed for p21 (Sheaff et al., 2000) and EF1a to confirm equal amounts of protein. The positions of the VHLp18(MEA), elongin B, cul-2, p21 and EF1a are indicated to the left of the figure. The time of harvest is indicated below the figure. Control lane labeled scraped contains extract from confluent MEA-2 cells collected by mechanical detachment using a cell scraper Figure 8 pVHL is downregulated by E-cadherin-mediated disruption of cell-cell contact. Confluent MCF-7 cells were treated with or without 5 mm EGTA added directly to the media for 2, 4 and 6 h (as indicated above lanes) and then harvested. pVHL, EF1a (loading control) and E-cadherin expression were determined in the cell lysates by Western blot. The positions of the VHLp24(MPR), VHLp18(MEA), E-cadherin and EF1a are indicated to the left of the figure VHL regulation by cell density S Mohan and RD Burk pVHL contains a cell density-dependent region
To examine whether a particular domain on pVHL mediates the density-dependent regulation of pVHL, we utilized VHL-GFP deletion constructs stably transfected into 786-O cells ). The resulting cell lines were plated under sparse and dense conditions and analysed for pVHL-GFP levels by Western blotting using an anti-GFP antibody. The GFP protein showed no density-dependent variation in protein levels (Figure 10a ). All constructs except VHL (1-154) and VHL(155-177) showed density-dependent expression, indicating that constructs with pVHL terminal region amino acids 172-213 were able to impart density-dependent regulation to a heterologous protein (Figure 10a ). The region from 172 to 213 amino acid was termed the CDDR. In addition, we also examined the effects of disrupting the elongin-binding domain by testing constructs containing mutations in this region (i.e., Arg-167 to Trp (R167W), Arg-161 to Gln/Cys-162 to Trp (RC161/2QW) and del 114-178) on pVHL density-dependent expression (Figure 10b ). All the three elongin-binding mutants showed densitydependent regulation indicating that elongin binding does not play a critical role in density-dependent regulation of pVHL.
Discussion
In the present study, we report that VHL tumor suppressor protein levels are cell density-dependent and require the carboxyl portion of the protein for this regulation. We demonstrate that a variety of human cell lines derived from renal, breast, bladder and lung showed density-dependent expression of pVHL indicating that this is a generalized phenomenon. Cell density-dependent regulation of protein levels may occur through transcriptional, translational or post-translational mechanisms. Analysis of VHL mRNA levels at different cell densities indicated that induction of pVHL at high cell density is not transcriptionally regulated. Further, pVHL disappears when confluent cells were released by either trypsin/ EDTA or EDTA alone and replated at low density. This decline was partially blocked by treating cells with a proteasomal inhibitor indicating that the density-dependent regulation of pVHL is mediated, at least in part, by proteasome-dependent degradation. Moreover, not only were levels of pVHL density-dependent, but the components of the VBC complex also showed a similar regulation. Consistent with the requirement of pVHL and the VBC complex to degrade HIF-alpha under normoxic conditions, the diminished presence of pVHL and the VBC complex at low cell density was associated with increased levels of HIF-2a in all cell lines examined.
Cell density recognition represents a signaling pathway that is present in bacteria through man. Whereas bacteria sense cell density through quorum-sensing diffusible transcriptional regulators (Fuqua et al., 1996) , higher-order eukaryote cells are thought to recognize and signal cell density through cell-cell contacts. However, the complete pathways and significance of cell density signal transduction in mammalian cells is largely unexplored. High cell density has been noted to influence a variety of cellular phenomena, such as renal (Amsler, 1994) , hepatic (Kojima et al., 2000) and epidermal keratinocyte (Lee et al., 1998b) differentiation, positive and negative transcriptional regulation (Singh et al., 1996; Hornyak et al., 2000; Lindon et al., 2001 ) and protein kinase and phosphatase activities (Ostman et al., 1994; Lallemand et al., 1998) .
Consistent with our finding, Baba et al. (2001) also showed that the expression of pVHL is cell densitydependent. They reported that VHL negative renal carcinoma cells continued to grow after attaining confluence and that VHL positive cells underwent cell cycle arrest. We detected no growth arrest attributed to VHL with cells grown on plastic, but have noted VHLdependent growth arrest on the ECM of confluent cells . Pause et al. (1998) reported that both VHL-positive and -negative 786-O cells undergo cell cycle arrest at high cell density. Thus, the discrepancy between these findings cannot be easily resolved. Cell-cell contact-induced gene expression may occur via mechanisms that induce growth arrest at confluence. However, in the present study, pVHL expression dramatically increased at day 2 (Figure 3 ) when the cells were not 100% confluent, indicating that pVHL is induced with minimal cell-cell contact and the levels continue to increase as the cells become more dense. This suggests that expression of pVHL is increased at cell densities below confluence, implying that contact inhibition and growth arrest are not required for induction of pVHL.
The cell density-dependent regulation of pVHL was not related to cell cycle arrest. When growth arrest was induced by serum starvation of ECV304 cells, no increase in pVHL levels was noted relative to cells proliferating in the presence of serum (data not shown). Previous studies also indicated that cell density but not cell cycle control influenced VHL-mediated renal cell differentiation ) and subcellular localization of pVHL (Lee et al., 1996) .
Cell density could exert its effect through the production of soluble factor(s) that might modulate the expression of pVHL. However, medium from cells Figure 1 . In all, 40 mg of total protein from each lysate were separated on 10% SDS-PAGE and HIF-2a protein was detected with a mAb. The position of the HIF-2a is indicated on the left side of the figure VHL regulation by cell density S Mohan and RD Burk grown at high cell density did not alter expression of pVHL in cells grown at low cell density. It has been reported that cell shape influences growth control and DNA synthesis of normal cells (Folkman and Moscona, 1978) . To examine the role of cell shape and cell-ECM contact on pVHL expression, cells were plated on poly(HEMA)-coated plates that do not facilitate cell attachment to the substratum. Cells expressing pVHL and grown on poly(HEMA) also showed density-dependent pVHL regulation, suggesting that cell shape, spreading and cell-ECM contact are not critical for the density-dependent regulation of pVHL, but suggest a role for cell-cell contacts. Furthermore, decreases in pVHL levels in MCF-7 cells after treatment with EGTA support the notion that density-dependent regulation of pVHL is modulated by cell-cell contact.
In order to understand the biochemical basis of cell density-dependent regulation of pVHL, we performed a deletion analysis of VHL fused to the reporter, GFP, to localize the region of VHL involved in modulating its density-dependent regulation. All VHL proteins containing amino acids 172-213 demonstrated densitydependent regulation. Constructs not containing this region (e.g., aa 1-154, 155-177) showed equal levels of expression under sparse and dense conditions, whereas the other constructs showed density-dependent regulation. Thus, we identified a region of the VHL protein that was necessary to impart a cell density-dependent phenotype to a heterologous protein. This function is located in the carboxyl 41 aa of pVHL, separate from the elongin-binding domain. This region encompasses a portion of the alpha domain and the carboxyl-beta domain, as deduced from the crystal structure of VHL (Stebbins et al., 1999) .
We observed that other components of the VBC complex (e.g., elongin B/C and cul-2) also exhibited density-dependent regulation, both in 786-O and 786-O cells stably expressing pVHL. Like VHL, the VBC complex proteins were protected from undergoing degradation under sparse conditions when treated with a proteasomal inhibitor. The independent densitydependent regulation of VHL and other members of the VBC complex were indicated by two observations. First, VHL mutations that block elongin binding did not affect the density-dependent expression of VHL. Second, elongin B/C and cul-2 demonstrated densitydependent regulation in cells lacking VHL. Taken together, these observations suggest redundancy in the density-dependent regulation of the VBC complex and its function. Furthermore, the idea that elongin C was in vast excess of VHL and thus not susceptible to stoichiometric sequestration from other protein interactions needs to be re-examined. It has been reported that the association of pVHL with TRiC is required for the formation of VBC -tumor suppressor complex (Feldman et al., 1999) . We investigated the expression of TRiC under sparse and dense conditions in different cell lines. The level of TRiC was unchanged with respect to cell density (data not shown). This suggests that not all VHL-associating proteins are cell density regulated. Also, the levels of pRb (data not shown) were unchanged under sparse and confluent conditions, suggesting that not all tumor suppressor genes are regulated by cell density. Subcellular localization of pVHL was shown to be cell density-dependent (Lee et al., 1996) , but the dynamic changes in the amount of pVHL level were not documented in these experiments. We examined the expression of pVHL under sparse and confluent conditions by subcellular fractionation of 786-O cells stably expressing VHL p24(MPR) (data not shown). Our results suggested that under high and low cell density conditions, pVHL is predominantly localized in the cytoplasm. However, the levels of pVHL were several fold higher in cells grown to high compared to low cell density.
When confluent cells were trypsinized and replated at sparse, medium and dense conditions, pVHL was detected at 6 h only in the cells replated at high cell density (data not shown). However, when sparsely plated cells were treated with a proteasomal inhibitor, pVHL levels were not as abundant as those seen in the densely plated cells at 6 h (data not shown). These results suggest that pVHL synthesis may also be increased at high cell density.
The VBC ubiquitin ligase complex has been shown to mediate proteasomal degradation of HIF-1/2a under normoxic conditions (Cockman et al., 2000; Kamura et al., 2000; Ohh et al., 2000; Tanimoto et al., 2000) . Since cell density regulates pVHL abundance, we predicted that HIF-1/2a would be elevated in culture conditions with low or absent levels of pVHL and/or VBC. Consistent with this hypothesis, HIF-2a levels were higher in sparsely grown cells compared to cells grown at high cell density. However, cells with mutant VHL (i.e., 786-0) did not show cell density-dependent regulation of HIF-2a. Furthermore, reintroduction of native but not mutant VHL in 786-O cells restored the cell density-dependent regulation of HIF-2a. This indicates that pVHL is necessary for the cell densitydependent regulation of HIF-2a, consistent with pVHL's role as an E3-ubiquitin ligase for HIF-2a (Cockman et al., 2000; Kamura et al., 2000; Ohh et al., 2000; Tanimoto et al., 2000) .
In conclusion, we provide evidence that pVHL expression is regulated by cell density and this regulation is independent of elongin binding and requires the carboxyl portion of pVHL. These results imply that this region of VHL interacts with or is modified by other molecules, the identity of which is under investigation. Moreover, regulation of pVHL had functional consequences as indicated by the inverse abundance of HIF2a with pVHL. These results also explain the cell density dependence of both pVHL-induced growth arrest on ECM and renal cell differentiation. Furthermore, care must be taken when interpreting studies of VHL function and subcellular localization of cells grown at subconfluent conditions.
Materials and methods
Cell culture
Cell lines 786-O, ACHN, Caki-1, HK-2, MCF7, CCF-RC2 and WI-38 were obtained from the American Type Culture Collection (Manassas, VA, USA). 293 T and ECV304 cells were kindly provided by Richard Pestell and Anthony Ware (Albert Einstein College of Medicine), respectively. 786-O cells stably expressing VHLp24(MPR), VHLp18(MEA) and VHL-GFP constructs have been previously described (Schoenfeld et al., 1998 ). All cell lines except WI-38, were grown in Dulbecco's modified Eagle's medium (DMEM) (Mediatech Inc., Herndon, VA, USA) containing 10% fetal calf serum (FCS) and penicillin (100 IU/ml)-streptomycin (100 mg/ml). WI-38 cells were grown in Eagle's minimal essential medium (EMEM) (GibcoBRL Life Technologies, Gaithersburg, MD, USA) with Earle's balanced salt solution (EBSS), 2 mm lglutamine, 1.0 mm sodium pyruvate, 0.1 mm nonessential amino acids and 1.5 g/l sodium bicarbonate. Cells were cultured in 100 mm plastic culture dishes (Corning Inc., Corning, NY, USA) in a humidified incubator maintained at 371C and 5% CO 2 . To maintain cells at high density, cells were allowed to grow for 1 week postconfluency with media replenishment every 24-48 h. Confluent cells were released by treatment with 0.05% Trypsin-0.53 mm EDTA (Mediatech Inc.). For the time point experiments, confluent cells were released by treatment with 0.1% EDTA (JT Baker Inc. Phillipsburg, NJ, USA), resuspended in media at 371C and gently rocked to keep cells from settling until harvest. The proteasome inhibitor, carbobenzoxy-l-leucyl-l-leucyl-lleucinal (MG-132, Calbiochem, La Jolla, CA, USA) was dissolved in DMSO (Sigma, St Louis, MO, USA) and used at a final concentration of 50 mm.
RT-PCR analyses
Total RNA was isolated using an Rneasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol. Total RNA (5 mg) was subjected to reverse transcription using random primers and M-MuLV reverse transcriptase (Stratagene, La Jolla, CA, USA) in a 50 ml reaction volume for 60 min at 371C. The RT reaction product (1 ml) was then subjected to 35 cycles of multiplex PCR. The VHL primers (forward 5 0 -CCCAGGTCATCTTCTGCAAT-3 0 and reverse 5 0 -TGAC-GATGTCCAGTC TCCTG-3 0 ) were designed to amplify a 330 bp fragment spanning two exon-intron junctions and were combined with b-actin primers (forward 5 0 -CACACTGTGC-CCATC TACGA-3 0 and reverse 5 0 -TAGAAGCATTT-GCGGTGGAC-3 0 ) that amplified a 647 bp fragment in a single PCR reaction. The PCR products were run on 1.5% agarose gel and visualized by ethidium bromide staining.
Northern blotting and autoradiography
In all, 20 mg of total RNA were separated in a formaldehydeagarose gel and transferred to a Biodyne B nylon membrane (GibcoBRL Life Technologies) using 20 Â SSC. RNA was fixed on the membrane by baking at 801C for 30 min. A 0.7 kb probe for VHL was generated by cleaving cloned VHL with HindIII and XhoI and a 0.65 kb probe for actin was generated by RT-PCR, using the primers indicated above. The DNA fragments were isolated and labeled with a[ 32 P]dCTP using the Radprime DNA labeling system (GibcoBRL Life Technologies). Hybridization was performed using Perfecthyb Plus hybridization buffer (Sigma). The blots were washed at high stringency and exposed to hyperfilm (Amersham Pharmacia Biotech, Buckinghamshire, UK).
Antibodies and Western blotting
Adherent cells on the tissue culture plates or cells obtained by EDTA treatment were washed twice with PBS and lysed with 1 ml of 2 Â sodium dodecyl sulfate (SDS) loading buffer (100 mm Tris-HCl pH 6.8, 200 mm dithiothreitol, 4% SDS, 20% glycerol) per 100 mm plate. Lysates were immediately heated at 1001C for 10 min, sonicated and assayed for protein concentration by the Bradford assay (Bio-Rad, Hercules, CA, USA). Equivalent amounts of each lysate were separated by 13.5% SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA, USA). Membranes were blocked with 8% powdered nonfat dry milk in 1 Â Tris-buffered saline, Tween-20 (TBST) buffer (10 mm Tris-HCl pH 8.0, 150 mm NaCl, 0.05% Tween 20) and analysed by Western blotting. Monoclonal antibody (mAb) against VHL (11E12) was used as previously described (Schoenfeld et al., 1998) and primary antibodies against elongin B and C (Santa Cruz Biotechnology, Santa Cruz, CA, USA), cul-2 (Transduction Laboratories, San Diego, CA, USA), Flag epitope mAb (Flag-M5, Sigma), GFP (Clontech, Palo Alto, CA, USA), p21 (Calbiochem), HIF-2a (Novus Biologicals, Littleton, CO, USA), E-cadherin (Zymed Laboratories Inc., South San Francisco, CA, USA) and elongation factor 1 a (EF1a) (Upstate Biotechnology, Lake Placid, NY, USA) were used as recommended by the manufacturers. Primary antibodies were diluted in 1 Â TBST buffer and incubated for 1 h. Secondary antibodies (anti-mouse, goat and anti-rabbit) were diluted 1 : 5000 in 1 Â TBST buffer and incubated for 1 h. ECL was performed for Westerns as suggested by the manufacturer (Amersham Pharmacia Biotech).
Growth of cells on Poly(HEMA)
Six grams of [poly(HEMA)] (Sigma) were added to 50 ml of 95% ethanol and dissolved at 371C overnight. The solution was clarified by centrifugation at 2500 r.p.m. for 30 min. This stock solution was diluted 1 : 10 with 95% ethanol and directly applied on 100 mm plastic culture dishes. The plates were allowed to dry for 48 h. Confluent ECV304 cells were trypsinized and replated at 0.2 and 7.0 Â 10 6 cells per 100 mm poly(HEMA)-coated tissue culture dish and harvested for Western blot after 24 h.
Disruption of cell-cell contact
MCF-7 cells were seeded at 1.0 Â 10 6. cells per 100 mm plate and grown to confluence for 24 h. Cell-cell contact was disrupted by the addition of 5 mm EGTA. Cells were harvested at 2, 4 and 6 h after addition of EGTA. Cells were examined by light microscopy at several time points to ensure cell viability and to record morphological changes induced by EGTA treatment. Protein expression was analysed as described above.
